Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -1536.91% is 1269% below its 5-year average of -112.30%, near the high end of its 5-year range (-19023.53%–0.00%).
18.14% below its 12-month average of -1300.97%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -119.97%.
OPERATING MARGIN
-1536.91%
OPERATING MARGIN AVG TTM
-1300.97%
OPERATING MARGIN AVG 3Y
-92.36%
OPERATING MARGIN AVG 5Y
-112.30%
OPERATING MARGIN AVG 10Y
-844.60%
OPERATING MARGIN AVG 15Y
-629.59%
OPERATING MARGIN AVG 20Y
-975.40%
CURRENT VS TTM AVG
-18.14%
CURRENT VS 3Y AVG
-1563.97%
CURRENT VS 5Y AVG
-1268.53%
CURRENT VS 10Y AVG
-81.97%
CURRENT VS 15Y AVG
-144.11%
CURRENT VS 20Y AVG
-57.57%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 644 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Abeona Therapeutics Inc.
Market Cap
$286.40M
Operating Margin
-1536.91%
TTM Avg
-1300.97%
3Y Avg
-92.36%
5Y Avg
-112.30%
Market Cap
$283.44M
Operating Margin
0.00%
TTM Avg
-13.69%
3Y Avg
-1436.87%
5Y Avg
-1163.68%
Market Cap
$290.35M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$292.42M
Operating Margin
-109.34%
TTM Avg
-104.90%
3Y Avg
-100.12%
5Y Avg
-81.51%
Market Cap
$293.99M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$278.45M
Operating Margin
-14.55%
TTM Avg
-6.56%
3Y Avg
-30.72%
5Y Avg
-57.13%
Market Cap
$275.74M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$275.66M
Operating Margin
-2222.45%
TTM Avg
-1882.54%
3Y Avg
-1096.29%
5Y Avg
-863.53%
Market Cap
$304.97M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-6360.33%
5Y Avg
-12157.15%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Abeona Therapeutics Inc. (ABEO) | $286.40M | -1536.91% | -1300.97% | -92.36% | -112.30% |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $283.44M | 0.00% | -13.69% | -1436.87% | -1163.68% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $290.35M | 0.00% | 0.00% | 0.00% | 0.00% |
| Standard BioTools Inc. (LAB)vs › | $292.42M | -109.34% | -104.90% | -100.12% | -81.51% |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $293.99M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aurora Cannabis Inc. (ACB)vs › | $278.45M | -14.55% | -6.56% | -30.72% | -57.13% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $275.74M | 0.00% | 0.00% | 0.00% | 0.00% |
| Fate Therapeutics, Inc. (FATE)vs › | $275.66M | -2222.45% | -1882.54% | -1096.29% | -863.53% |
| Benitec Biopharma Inc. (BNTC)vs › | $304.97M | 0.00% | 0.00% | -6360.33% | -12157.15% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $267.45M | -775.98% | -556.52% | -379.20% | -295.79% |
Gross Margin
73.7%
Operating Margin
-1536.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -119.97% |
| 2026-03-31 | -264.14% |
| 2025-12-31 | -422.71% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | -5698.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | -301.54% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | -19023.53% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | -800.80% |
| 2022-03-31 | -5951.16% |
| 2021-12-31 | -1555.07% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | -482.67% |
| 2020-09-30 | -89.26% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 968.98% |
| 2018-09-30 | -989.82% |
| 2018-06-30 | -4549.64% |
| 2018-03-31 | -2011.86% |
| 2017-12-31 | -4069.77% |
| 2017-09-30 | -2448.40% |
| 2017-06-30 | -3889.40% |
| 2017-03-31 | -2840.86% |
| 2016-12-31 | -2278.13% |
| 2016-09-30 | -2811.96% |
| 2016-06-30 | -3137.85% |
| 2016-03-31 | -2621.28% |
| 2015-12-31 | -2908.37% |
| 2015-09-30 | -2162.81% |
| 2015-06-30 | -1463.48% |
| 2015-03-31 | -775.97% |
| 2014-12-31 | -199.57% |
| 2014-09-30 | -268.22% |
| 2014-06-30 | -284.62% |
| 2014-03-31 | -638.46% |
| 2013-12-31 | -422.22% |
| 2013-09-30 | -368.25% |
| 2013-06-30 | -411.35% |
| 2013-03-31 | -41.09% |
| 2012-12-31 | -121.17% |
| 2012-09-30 | -109.76% |
| 2012-06-30 | -210.43% |
| 2012-03-31 | -37.14% |
| 2011-12-31 | -333.99% |
| 2011-09-30 | -171.37% |
| 2011-06-30 | -1492.05% |
| 2011-03-31 | -1432.67% |
| 2010-12-31 | -1277.55% |
| 2010-09-30 | -1807.87% |
| 2010-06-30 | -1847.62% |
| 2010-03-31 | -1610.78% |
| 2009-12-31 | -1620.19% |
| 2009-09-30 | -2736111.11% |
| 2009-06-30 | -3320.63% |
| 2009-03-31 | -4778.05% |
| 2008-12-31 | -1966.22% |
| 2008-09-30 | -8234.04% |
| 2008-06-30 | -1632.58% |
| 2008-03-31 | -27797.37% |
| 2007-12-31 | -3749.02% |
| 2007-09-30 | -27516.67% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 392.51% |
| 2005-09-30 | -500.00% |
| 2005-06-30 | -1025.30% |
| 2005-03-31 | -847.10% |
| 2004-12-31 | -945.65% |
| 2004-09-30 | -1204.86% |
| 2004-06-30 | -3200.00% |
| 2004-03-31 | -10320.00% |
| 2003-12-31 | -1145.19% |
| 2003-09-30 | -17663.64% |
| 2003-06-30 | -248.02% |
| 2003-03-31 | -558.27% |
| 2002-12-31 | -316.69% |
| 2002-09-30 | -2939.56% |
